Search research articles
Contact Us
Filters
Showing results (1-10 of 16) with videos related to
Page
of 2
Sort By:
Journal of Hospital Medicine
|
April 16, 2010
Self-medication and intractable cough
Matthew C Stewart, Yvette Kasamon
The Lancet. Oncology
|
April 17, 2022
The saga of PI3K inhibitors in haematological malignancies: survival is the ultimate safety endpoint
Nicholas C Richardson, Yvette Kasamon, Richard Pazdur, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 1, 2009
From RECIST to PERCIST: Evolving Considerations for PET response criteria in solid tumors
Richard L Wahl, Heather Jacene, Yvette Kasamon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 17, 2023
Irreconcilable Differences: The Divorce Between Response Rates, Progression-Free Survival, and Overall Survival
Margret Merino, Yvette Kasamon, Marc Theoret, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 7, 2013
Radiobiologic optimization of combination radiopharmaceutical therapy applied to myeloablative treatment of non-Hodgkin lymphoma
Robert F Hobbs, Richard L Wahl, Eric C Frey, et al.
Leukemia & Lymphoma
|
August 20, 2011
Importance of immunoglobulin heavy chain variable region mutational status in del(13q) chronic lymphocytic leukemia
Douglas E Gladstone, Lode Swinnen, Yvette Kasamon, et al.
Clinical Immunology (Orlando, Fla.)
|
June 15, 2014
A phase I study of PRO131921, a novel anti-CD20 monoclonal antibody in patients with relapsed/refractory CD20+ indolent NHL: correlation between clinical responses and AUC pharmacokinetics
Carla Casulo, Julie M Vose, William Y Ho, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
January 31, 2012
The importance of IGHV mutational status in del(11q) and del(17p) chronic lymphocytic leukemia
Douglas E Gladstone, Amanda Blackford, Eunpi Cho, et al.
Leukemia & Lymphoma
|
August 1, 2012
Human leukocyte antigen-haploidentical hematopoietic stem cell transplant for a patient with histiocytic sarcoma
Amer Zeidan, Javier Bolaños-Meade, Yvette Kasamon, et al.
Pediatric Blood & Cancer
|
May 13, 2022
FDA approval summary: Crizotinib for pediatric and young adult patients with relapsed or refractory systemic anaplastic large cell lymphoma
Margret Merino, Yvette Kasamon, Hongshan Li, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 16) with videos related to
Sort By:
Page
of 2
Journal of Hospital Medicine
|
April 16, 2010
Self-medication and intractable cough
Matthew C Stewart, Yvette Kasamon
The Lancet. Oncology
|
April 17, 2022
The saga of PI3K inhibitors in haematological malignancies: survival is the ultimate safety endpoint
Nicholas C Richardson, Yvette Kasamon, Richard Pazdur, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 1, 2009
From RECIST to PERCIST: Evolving Considerations for PET response criteria in solid tumors
Richard L Wahl, Heather Jacene, Yvette Kasamon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 17, 2023
Irreconcilable Differences: The Divorce Between Response Rates, Progression-Free Survival, and Overall Survival
Margret Merino, Yvette Kasamon, Marc Theoret, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 7, 2013
Radiobiologic optimization of combination radiopharmaceutical therapy applied to myeloablative treatment of non-Hodgkin lymphoma
Robert F Hobbs, Richard L Wahl, Eric C Frey, et al.
Leukemia & Lymphoma
|
August 20, 2011
Importance of immunoglobulin heavy chain variable region mutational status in del(13q) chronic lymphocytic leukemia
Douglas E Gladstone, Lode Swinnen, Yvette Kasamon, et al.
Clinical Immunology (Orlando, Fla.)
|
June 15, 2014
A phase I study of PRO131921, a novel anti-CD20 monoclonal antibody in patients with relapsed/refractory CD20+ indolent NHL: correlation between clinical responses and AUC pharmacokinetics
Carla Casulo, Julie M Vose, William Y Ho, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
January 31, 2012
The importance of IGHV mutational status in del(11q) and del(17p) chronic lymphocytic leukemia
Douglas E Gladstone, Amanda Blackford, Eunpi Cho, et al.
Leukemia & Lymphoma
|
August 1, 2012
Human leukocyte antigen-haploidentical hematopoietic stem cell transplant for a patient with histiocytic sarcoma
Amer Zeidan, Javier Bolaños-Meade, Yvette Kasamon, et al.
Pediatric Blood & Cancer
|
May 13, 2022
FDA approval summary: Crizotinib for pediatric and young adult patients with relapsed or refractory systemic anaplastic large cell lymphoma
Margret Merino, Yvette Kasamon, Hongshan Li, et al.
Page
of 2